Anti-cancer activity and potential mechanism of a novel aspirin derivative.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  European Journal of Pharmacology

• Publication date

  2016-11-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ejphar.2016.07.050PMID 27565221
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aspirin blocks growth of breast tumor cells and tumor-initiating cells and induces reprogramming factors of mesenchymal to epithelial transition

  2015cited by this paper
• A novel aspirin prodrug inhibits NFκB activity and breast cancer stem cell properties

  2015cited by this paper
• Novel Resveratrol-Based Aspirin Prodrugs: Synthesis, Metabolism, and Anticancer Activity.

  2015cited by this paper
• Regular aspirin use and stomach cancer risk in China.

  2015cited by this paper
• COX-2 overexpression and -8473 T/C polymorphism in 3′ UTR in non-small cell lung cancer

  2014cited by this paper
• Molecular Pathways: Aspirin and Wnt Signaling—A Molecularly Targeted Approach to Cancer Prevention and Treatment

  2014cited by this paper
• Role of platelets in inflammation and cancer: novel therapeutic strategies.

  2014cited by this paper
• Preparation and Characterization of a Novel Aspirin Derivative with Anti-Thrombotic and Gastric Mucosal Protection Properties

  2014cited by this paper
• Expression of caspase-3 predicts prognosis in advanced noncardia gastric cancer

  2014cited by this paper
• Design, synthesis and biological evaluation of novel antagonist compounds of Toll-like receptors 7, 8 and 9

  2013cited by this paper
• Low-dose aspirin use and cancer characteristics: a population-based cohort study

  2013cited by this paper
• Aspirin and Colorectal Cancer: Back to the Future

  2013cited by this paper
• Gastric cytoprotection beyond prostaglandins: cellular and molecular mechanisms of gastroprotective and ulcer healing actions of antacids.

  2012cited by this paper
• E series prostaglandins alter the proliferative, apoptotic and migratory properties of T98G human glioma cells in vitro

  2012cited by this paper
• Mechanistic and Pharmacological Issues of Aspirin as an Anticancer Agent

  2012cited by this paper
• Protection against LPS-induced cartilage inflammation and degradation provided by a biological extract of Mentha spicata

  2010cited by this paper
• The role of prostaglandin E2 (PGE 2) in toll-like receptor 4 (TLR4)-mediated colitis-associated neoplasia

  2010cited by this paper
• Effect of aspirin on proliferation and nuclear factor kappa B p65 expression in gastric cancer cell line SGC-7901

  2009cited by this paper
• NCX-4016, a nitro-derivative of aspirin, inhibits EGFR and STAT3 signaling and mdulates Bcl-2 proteins in cisplatin-resistant human ovarian cancer cells and xenografts

  2008cited by this paper
• The cyclooxygenase‐2‐mediated prostaglandin signaling is causally related to epithelial carcinogenesis

  2007cited by this paper
• Prostaglandin E2 stimulates progression-related gene expression in early colorectal adenoma cells

  2006cited by this paper
• Role of cyclooxygenase-2 in the carcinogenesis of gastrointestinal tract cancers: a review and report of personal experience.

  2006cited by this paper
• Nitric oxide–releasing aspirin and indomethacin are potent inhibitors against colon cancer in azoxymethane-treated rats: effects on molecular targets

  2006cited by this paper
• Relationship between the expression of human telomerase reverse transcriptase gene and cell cycle regulators in gastric cancer and its significance.

  2003cited by this paper
• Role of cyclooxygenase-2 in the development and treatment of oesophageal adenocarcinoma.

  2003cited by this paper
• Overexpression of the wild-type p53 gene inhibits NF-κB activity and synergizes with aspirin to induce apoptosis in human colon cancer cells

  2000cited by this paper
• Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

  1999cited by this paper
• Expression of cyclooxygenase-2 in human gastric carcinoma.

  1997cited by this paper
• Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway.

  1996cited by this paper

• Antiproliferative Impact of Linagliptin on the Cervical Cancer Cell Line

  2024cites this paper
• Aspirin Exerts Its Antitumor Effect in Esophageal Squamous Cell Carcinoma by Downregulating the Expression of ATAD2 and KIF4A

  2022cites this paper
• Metformin suppresses breast cancer growth via inhibition of cyclooxygenase-2

  2021cites this paper
• Aspirin induces Beclin‐1‐dependent autophagy of human hepatocellular carcinoma cell

  2018cites this paper
• Effect of photodynamic therapy combined with Celecoxib on expression of cyclooxygenase-2 protein in HeLa cells.

  2018cites this paper
• Aspirin inhibits the proliferation of synovium-derived mesenchymal stem cells by arresting the cell cycle in the G0/G1 phase.

  2017cites this paper
• Acetylsalicylic acid inhibits the growth of melanoma tumors via SOX2-dependent-PAF-R-independent signaling pathway

  2017cites this paper
• Induction of senescence in cancer cells by 5′-Aza-2′-deoxycytidine: Bioinformatics and experimental insights to its targets

  2017cites this paper
• Implications of Aspirin for Melanoma Treatment: A Short Perspective

  2017cites this paper
• Ambroxol enhances anti-cancer effect of microtubule-stabilizing drug to lung carcinoma through blocking autophagic flux in lysosome-dependent way.

  2017cites this paper
• Ovarian Damages Produced by Aerosolized Fine Particulate Matter (PM2.5) Pollution in Mice: Possible Protective Medications and Mechanisms

  2017cites this paper